Literature DB >> 32172474

Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.

Aida Orois1,2, Celia Badenas3,4,5, Jordi L Reverter6, Verónica López3,4,5, Miriam Potrony3,4,5, Mireia Mora7,4,8,9, Irene Halperin7, Josep Oriola3,4,8.   

Abstract

To date, the genes involved in familial non-medullary thyroid cancer (FNMTC) remain poorly understood, with the exception of syndromic cases of FNMTC. It has been proposed that germline mutations in telomere-related genes, such as POT1, described in familial melanoma might also predispose individuals to thyroid cancer, requiring further research. We aimed to identify germline mutations in POT1 in selected FNMTC families (with at least three affected members) without a history of other cancers or other features, and to describe the clinical characteristics of these families. Sequencing of the 5'UTR and coding regions of POT1 was performed in seven affected people (index cases) from seven families with FNMTC. In addition, we performed whole-exome sequencing (WES) of DNA from 10 affected individuals belonging to four of these families. We did not find germline variants of interest in POT1 by Sanger sequencing or WES. We neither found putative causative mutations in genes previously described as candidate genes for FNMTC in the 4 families studied by WES. In our study, no germline potentially pathogenic mutations were detected in POT1, minimizing the possibilities that this gene could be substantially involved in non-syndromic FNMTC.

Entities:  

Keywords:  Familial non-medullary thyroid cancer; Germline; POT1; Telomere

Mesh:

Substances:

Year:  2020        PMID: 32172474     DOI: 10.1007/s12672-020-00383-5

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  25 in total

1.  On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds.

Authors:  N David Charkes
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

2.  Letter regarding the article: "Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls" by Kern et al.

Authors:  Carla Colombo; Laura Fugazzola; Marina Muzza; Maria Carla Proverbio; Valentina Cirello
Journal:  Eur J Med Genet       Date:  2017-08-02       Impact factor: 2.708

3.  Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).

Authors:  Joana S Pereira; Joana Gomes da Silva; Rute Alexandra Tomaz; António Evaristo Pinto; Maria João Bugalho; Valeriano Leite; Branca Maria Cavaco
Journal:  Endocrine       Date:  2014-11-09       Impact factor: 3.633

Review 4.  Hereditary thyroid cancer syndromes and genetic testing.

Authors:  Kathryn J Rowland; Jeffrey F Moley
Journal:  J Surg Oncol       Date:  2014-10-28       Impact factor: 3.454

5.  Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.

Authors:  Marco Capezzone; Silvia Cantara; Stefania Marchisotta; Sebastiano Filetti; Maria Margherita De Santi; Benedetta Rossi; Giuseppe Ronga; Cosimo Durante; Furio Pacini
Journal:  J Clin Endocrinol Metab       Date:  2008-07-29       Impact factor: 5.958

6.  POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.

Authors:  M Potrony; J A Puig-Butille; M Ribera-Sola; V Iyer; C D Robles-Espinoza; P Aguilera; C Carrera; J Malvehy; C Badenas; M T Landi; D J Adams; S Puig
Journal:  Br J Dermatol       Date:  2019-02-27       Impact factor: 9.302

Review 7.  Hereditary non-medullary thyroid cancer.

Authors:  Electron Kebebew
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

8.  Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.

Authors:  Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Jon G Jonasson; Asgeir Sigurdsson; Jon T Bergthorsson; Huiling He; Thorarinn Blondal; Frank Geller; Margret Jakobsdottir; Droplaug N Magnusdottir; Sigurborg Matthiasdottir; Simon N Stacey; Oskar B Skarphedinsson; Hafdis Helgadottir; Wei Li; Rebecca Nagy; Esperanza Aguillo; Eduardo Faure; Enrique Prats; Berta Saez; Mariano Martinez; Gudmundur I Eyjolfsson; Unnur S Bjornsdottir; Hilma Holm; Kristleifur Kristjansson; Michael L Frigge; Hoskuldur Kristvinsson; Jeffrey R Gulcher; Thorvaldur Jonsson; Thorunn Rafnar; Hannes Hjartarsson; Jose I Mayordomo; Albert de la Chapelle; Jon Hrafnkelsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2009-02-06       Impact factor: 38.330

9.  Lack of mutations of the telomerase RNA component in familial papillary thyroid cancer with short telomeres.

Authors:  Silvia Cantara; Serena Capuano; Marco Capezzone; Michele Benigni; Milena Pisu; Stefania Marchisotta; Furio Pacini
Journal:  Thyroid       Date:  2012-02-03       Impact factor: 6.506

10.  A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.

Authors:  Oriol Calvete; Paula Martinez; Pablo Garcia-Pavia; Carlos Benitez-Buelga; Beatriz Paumard-Hernández; Victoria Fernandez; Fernando Dominguez; Clara Salas; Nuria Romero-Laorden; Jesus Garcia-Donas; Jaime Carrillo; Rosario Perona; Juan Carlos Triviño; Raquel Andrés; Juana María Cano; Bárbara Rivera; Luis Alonso-Pulpon; Fernando Setien; Manel Esteller; Sandra Rodriguez-Perales; Gaelle Bougeard; Tierry Frebourg; Miguel Urioste; Maria A Blasco; Javier Benítez
Journal:  Nat Commun       Date:  2015-09-25       Impact factor: 17.694

View more
  3 in total

Review 1.  Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates.

Authors:  José Manuel Cameselle-Teijeiro; Ozgur Mete; Sylvia L Asa; Virginia LiVolsi
Journal:  Endocr Pathol       Date:  2021-01-25       Impact factor: 3.943

Review 2.  Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys.

Authors:  María Sánchez-Ares; Soledad Cameselle-García; Ihab Abdulkader-Nallib; Gemma Rodríguez-Carnero; Carolina Beiras-Sarasquete; José Antonio Puñal-Rodríguez; José Manuel Cameselle-Teijeiro
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-28       Impact factor: 5.555

Review 3.  Is Melanoma Progression Affected by Thyroid Diseases?

Authors:  Salvatore Ulisse; Enke Baldini; Daniele Pironi; Federica Gagliardi; Domenico Tripodi; Augusto Lauro; Sabino Carbotta; Danilo Tarroni; Matteo D'Armiento; Aldo Morrone; Flavio Forte; Flaminia Frattaroli; Severino Persechino; Teresa Odorisio; Vito D'Andrea; Eleonora Lori; Salvatore Sorrenti
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.